ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CYCN Stock Ownership Breakdown

NASDAQ : CYCN

Cyclerion Therapeutics, Inc.

$2.50

-0.08-3.10%

At Close 4:00 PM

62.16

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CYCN Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares4.7

Short Percent Of Float7.09

Shares Outstanding2.55M

Shares Float1.78M

Shares Short119.73K

Short Ratio0.02

7.09%

Short % of Float

4.7%

Short % of Shares Outstanding

Market Insider CYCN

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

21.9% Percentage of Shares held by All Insiders

40.41% Percentage of Shares held by All Institutions

51.74% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 40.41% of CYCN shares are held by financial institutions. ARTAL GROUP S.A. is the top corporate investor, holding 552 shares valued at $2.00K. A 0.02% stake in Cyclerion Therapeutics, Inc. is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Sep 30, 2023	ARTAL GROUP S.A.	0.02%	552	2K	0	0

CYCN Insiders

Among the CYCN insiders holding of 21.9% of the stake in company, HECHT PETER M, Chief Executive Officer, holds the largest shares of 2.05M. BUSCH ANDREAS, Chief Innovation Officer, is the second largest CYCN insider with ownership of 254.7K shares. CURRIE MARK G, President and CSO, stands third with possession of 251.65K shares of that stake.

Insiders	Designation	Shares Held
HECHT PETER M	Chief Executive Officer	2.05M
BUSCH ANDREAS	Chief Innovation Officer	254.7K
CURRIE MARK G	President and CSO	251.65K
HUYETT WILLIAM	Chief Financial Officer	67.59K
WRIGHT CHRISTOPHER I	Chief Medical Officer	42.73K
GJINO ANJEZA	Chief Financial Officer	31.6K
SCHULMAN AMY W	director	21.64K
MCGUIRE TERRANCE	director	0
SLATE PATH CAPITAL LP	10 percent owner	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 21, 2024	SLATE PATH CAPITAL LP	SALE	1.55	357.88K	555.11K	0
Aug 09, 2023	MCGUIRE TERRANCE	SALE	3.40	8	27.16	0
Jun 03, 2021	HECHT PETER M	PURCHASE	3.28	823.17K	2.7M	2.05M
Jun 03, 2021	SLATE PATH CAPITAL LP	PURCHASE	3.12	961.54K	3M	7.16M
Jun 03, 2021	MCGUIRE TERRANCE	PURCHASE	3.12	3.32K	10.36K	24.96K
May 06, 2021	HECHT PETER M	PURCHASE	2.43	302K	733.86K	1.22M
May 05, 2021	HECHT PETER M	PURCHASE	2.53	398K	1.01M	922.53K
May 04, 2021	HECHT PETER M	PURCHASE	2.29	300K	687K	524.53K
Feb 25, 2021	GJINO ANJEZA	SALE	4.00	1.82K	7.3K	31.6K
Feb 25, 2021	WRIGHT CHRISTOPHER I	SALE	3.99	2.64K	10.52K	42.73K
Dec 28, 2020	CURRIE MARK G	SALE	3.01	20.11K	60.52K	251.65K
Nov 09, 2020	BUSCH ANDREAS	PURCHASE	2.53	125K	316.25K	254.7K
Nov 06, 2020	HUYETT WILLIAM	SALE	2.52	3.83K	9.64K	67.59K
Feb 21, 2020	HUYETT WILLIAM	SALE	5.12	3.56K	18.22K	71.42K
Dec 30, 2019	CURRIE MARK G	SALE	2.48	25K	62K	271.76K
Dec 27, 2019	CURRIE MARK G	SALE	2.55	25K	63.75K	296.76K
Nov 15, 2019	BUSCH ANDREAS	PURCHASE	1.82	125K	227.5K	125K
Nov 08, 2019	HUYETT WILLIAM	SALE	2.05	3.92K	8.04K	74.98K
Apr 08, 2019	SCHULMAN AMY W	PURCHASE	16.00	21.64K	346.16K	21.64K
Apr 08, 2019	MCGUIRE TERRANCE	PURCHASE	16.00	21.64K	346.16K	21.64K
Apr 02, 2019	CURRIE MARK G	PURCHASE	14.81	270.11K	4M	321.76K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter